IMPORTANT: Investment involves risks. Investment value may rise or fall. Past performance information presented is not indicative of future performance. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and the full list of risk factors. Investors should not base on this document alone to make investment decisions.

CSOP Nikkei 225 Daily (2x) Leveraged Product (the “Product”) is a sub-fund of CSOP Leveraged and Inverse Series, an umbrella unit trust established under Hong Kong law. Units of the Product (the “Units”) are traded in HKD on The Stock Exchange of Hong Kong Limited (the “SEHK”) like stocks. It is a futures-based product which invests directly in the nearest quarter futures contracts on the Index traded on the Osaka Exchange, Inc. (the “OSE”) in Japan (“Nikkei 225 Futures”) (and/or nearest quarter Nikkei 225 mini futures traded on the OSE (“Nikkei 225 mini”)), so as to provide Daily investment results which, before fees and expenses, closely correspond to twice (2x) the Daily performance of the Index. It is denominated in JPY. Creations and redemptions are in USD or JPY.

  • The Product is not intended for holding longer than one day as the performance of the Product over a period longer than one day will very likely differ in amount and possibly direction from the leveraged performance of the Index over that same period (e.g. the loss may be more than twice the fall in the Index).
  • The Product is subject to concentration risks as a result of tracking the leveraged performance of the Index which focuses on a single country (i.e. Japan). The value of the Product may be more volatile than that of a fund having a more diverse portfolio of investments. The value of the Product may be more susceptible to adverse economic, political, policy, foreign exchange, liquidity, tax, legal or regulatory event affecting the Japanese market.
  • The OSE has the right to suspend trading in any security traded thereon. The Japanese government or the regulators in Japan may also implement policies that may affect the Japanese financial market. All of these may have a negative impact on the Product.
  • The Product’s base currency is JPY and the underlying investments of the Product are primarily denominated in JPY, but cash creations and redemptions in the primary market will be in USD / JPY, while dividend distributions (if any) will be in HKD. The NAV of the Product may be affected unfavourably by fluctuations in the exchange rates between USD and JPY and by changes in exchange rate controls.
  • Payment of distributions out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment and may result in an immediate reduction of the NAV per Unit.
  • The OSE and the SEHK have different trading hours. As the OSE may be open when Units in the Product are not priced, the value of the Nikkei 225 Futures (and/or Nikkei 225 mini) in the Product’s portfolio may change at times when investors will not be able to purchase or sell the Product’s Units. Differences in trading hours between the OSE and the SEHK may also increase the level of premium or discount of the Unit price to its NAV.


The CSOP Nikkei 225 Index ETF (the “Product”) is a sub-fund of the CSOP ETF Series*(*This includes synthetic ETFs) (the “Trust”), which is an umbrella unit trust established under Hong Kong law. The Product is a passively managed index tracking exchange traded fund authorised under Chapter 8.6 of the Code on Unit Trusts and Mutual Funds (the “Code”). The units of the Product (the “Units”) are traded on The SEHK like stocks.

  • Concentration risk – The Product’s investments are concentrated in Japan. The value of the Product may be more volatile than that of a fund having a more diverse portfolio of investments and may be more susceptible to adverse event affecting the Japanese market.
  • Risks associated with Japan and the equity market in Japan – The Japanese economy is heavily dependent on international trade and may be adversely affected by protectionist measures, competition from emerging economies, political tensions with its trading partners and their economic conditions, natural disasters and commodity prices.
  • Risks associated with small / mid-capitalisation companies – The Product may invest in small and mid-sized companies. The stock of small and mid-capitalisation companies may have lower liquidity and their prices are more volatile to adverse economic developments than those of larger capitalisation companies in general.
  • Trading differences risks – As the Tokyo Stock Exchange may be open when Units in the Product are not priced, the value of the securities in the Product’s portfolio may change on days when investors will not be able to purchase or sell the Units. Differences in trading hours between the Tokyo Stock Exchange and the SEHK may also increase the level of premium or discount of the Unit price to its NAV.


CSOP Nikkei 225 Daily (-2x) Inverse Product (the “Product”) is a sub-fund of CSOP Leveraged and Inverse Series, an umbrella unit trust established under Hong Kong law. Units of the Product (the “Units”) are traded in HKD on the SEHK like stocks. It is a futures-based product which invests directly in the Nikkei 225 Futures (and/or Nikkei 225 mini), so as to provide Daily investment results which, before fees and expenses, closely correspond to two times inverse (-2x) of the Daily performance of the Index. It is denominated in JPY. Creations and redemptions are in USD or JPY.

  • The Product is not suitable for holding longer than one day as the performance of the Product over a period longer than one day will very likely differ in amount and possibly direction from two times the inverse performance of the Index over that same period (e.g. the loss may be more than two times the increase in the Index). This effect may be more pronounced for longer holding periods and in products with larger leverage factor and/or inverse exposure. Investors should not expect the actual percentage return of investing in the Product to be equal to two times the inverse percentage change in the Index for periods of longer than one day.
  • The Product is subject to concentration risks as a result of tracking the two times inverse performance of the Index which focuses on a single country (i.e. Japan). The value of the Product may be more volatile than that of a fund having a more diverse portfolio of investments. The value of the Product may be more susceptible to adverse economic, political, policy, foreign exchange, liquidity, tax, legal or regulatory event affecting the Japanese market.
  • The OSE has the right to suspend trading in any security traded thereon. The Japanese government or the regulators in Japan may also implement policies that may affect the Japanese financial market. All of these may have a negative impact on the Product.
  • The Product’s base currency is JPY and the underlying investments of the Product are primarily denominated in JPY, but cash creations and redemptions in the primary market will be in USD / JPY, while dividend distributions (if any) will be in HKD. The NAV of the Product may be affected unfavourably by fluctuations in the exchange rates between USD and JPY and by changes in exchange rate controls.
  • Payment of distributions out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment and may result in an immediate reduction of the NAV per Unit.
  • The OSE and the SEHK have different trading hours. As the OSE may be open when Units in the Product are not priced, the value of the Nikkei 225 Futures (and/or Nikkei 225 mini) in the Product’s portfolio may change at times when investors will not be able to purchase or sell the Product’s Units. Differences in trading hours between the OSE and the SEHK may also increase the level of premium or discount of the Unit price to its NAV.


Please note that the above listed investment risks are not exhaustive, and investors should read the Prospectus and the Product Key Facts for further details (including the full list risk factors) before making any investment decision.
CSOP Nikkei 225 Index ETF
CSOP Nikkei 225 Daily(2x) Leveraged Product
CSOP Nikket 225 Daily(-2x) Inverse Product
logo
CSOP Nikkei 225 Index ETF
Stock Code: 3153.HK
Short Name: CSOP NIKKEI225
Listing Date:
31 January 2024
Exchange:
Hong Kong Stock Exchange – Main Board
Index:
Nikkei Stock Average Index (net total return version)
Fund Manager:
CSOP Asset Management Limited
Investment Strategy:
This is a physical ETF. A full replication strategy
Base Currency:
Japanese Yen
Trading Currency:
Hong Kong Dollar
Trading Lot Size:
10 Units
Minimum Investment 1:
100 USD (~ 780 HKD)
Management Fee:
0.99% of the fund’s NAV per annum
Application Unit Size (only by or through Participating Dealers):
50,000 Units (or multiples thereof)
Ongoing charges over a year 2:
0.99% of the fund’s NAV per annum
Trustee:
HSBC Institutional Trust Services (Asia) Limited

Source: CSOP.
1 Estimated data, for reference only.
2 As the Fund is newly set up, this figure is a best estimate only and represents the sum of the estimated ongoing charges over a 12-month period, expressed as a percentage of the estimated average NAV over the same period. It may be different upon actual operation of the Fund and may vary from year to year. For the first 12-month period from the launch of the Fund, the ongoing charges figure is capped at 2% of the average ‎NAV of the Fund. Any ongoing expenses exceeding 2% of the average NAV of the Fund during this period will be ‎borne by the Manager and will not be charged to the Fund.‎
The above information is for reference only, and does not constitute an investment advice of, or an offer, solicitation, or recommendation to buy or sell any securities or investment products in any country or jurisdiction. Investment involves risk.

CSOP Nikkei 225 Daily (2x)
Leveraged Product
Stock Code: 7262.HK
Short Name: FL2 CSOP NIKKEI
CSOP Nikkei 225 Daily (-2x)
Inverse Product
Stock Code: 7515.HK
Short Name: FI2 CSOP NIKKEI
Listing Date:
29 May 2024
Exchange:
Hong Kong Stock Exchange – Main Board
Index:
Nikkei Stock Average
Fund Manager:
CSOP Asset Management Limited
Investment Strategy:
A futures-based replication strategy
Base Currency:
Japanese Yen
Trading Currency:
Hong Kong Dollar
Trading Lot Size:
10 Units
Minimum Investment 1:
100 USD (~ 780 HKD)
Management Fee:
1.60%
Application Unit Size (only by or through Participating Dealers):
Minimum 50,000 Units (or multiples thereof)
Ongoing charges over a year 2:
1.99%
Trustee:
HSBC Institutional Trust Services (Asia) Limited

Source: CSOP.
1 Estimated data, for reference only.
2 This is indicative only because the Product is newly set up. The annual average daily ongoing charges figure is equal to the ongoing charges figure over the first year of listing divided by the anticipated number of dealing days during that year. The actual figure may be different from the estimate figure and may vary from year to year.
The above information is for reference only, and does not constitute an investment advice of, or an offer, solicitation, or recommendation to buy or sell any securities or investment products in any country or jurisdiction. Investment involves risk.




Why Invest in

CSOP Nikkei 225 Index Product Series?

1. Global Triumph: Japanese Stocks Soar to a 34-Year High

The Nikkei 225 Index rose 30% in 2023, leading all major global markets. At the beginning of 2024, it climbed to a new peak, breaking through 34,000 points, setting a new high since March 1990 (when the asset bubble burst).





3 Source: Bloomberg, 12/30/2022 - 12/29/2023. Except for the Taiwan Stock Exchange Weighted Index (Bloomberg code: TWSE Index), all are net total return indices. H-Share-Hang Seng Index, A-Share-CSI300 Index, UK-FTSE 100 Index, Vietnam-FTSE Vietnam 30 Index, Saudi Arabia-FTSE Saudi Arabia Index, Australia-S&P/ASX 200 Index, APAC-FTSE Asia Pacific Low Carbon Select Index, France-CAC 40 Index, German-DAX Index, India-Nifty50 Index, Euro Zone-Euro STOXX Index, South Korea-KOSPI Index, US-S&P 500 Index, Taiwan China-TWSE Index, Japan-Nikkei 225 Index.
4 Source: Bloomberg. The Nikkei 225 Index - Price Return starts from the index base date of 12/28/1979, and the Nikkei 225 Index - Net Total Return starts from the earliest available data of 1/4/2002 on Bloomberg, standardized according to the index price level of 100 on 1/4/2002.
For illustration purpose only. Not to be constituted as a recommendation to buy/sell securities in the above-mentioned sectors or investment types.

2. Three Arrows Unleashed: A Surge in Attraction for the Japanese Stock Market

First Arrow: Buffett's Increased Stake Ignites Japanese Stocks

In April 2023, Warren Buffett visited Japan for the first time in 12 years. Subsequently, he repeatedly increased his holdings, making Japanese stocks his largest overseas investment. The world's attention is once again focused on this former Asian leader. After the trip to Japan, the "Buffett Effect" is significant, attracting the attention of overseas investors to the Japanese stock market, with many institutions buying Japanese stocks in large quantities.


2020:

  • Warren Buffett's investment group, Berkshire Hathaway, announced the purchase of more than 5% of shares in each of Japan's five leading trading groups - Mitsubishi Corp, Mitsui & Co., Itochu, Marubeni and Sumitomo Corp.

2022:

  • Berkshire Hathaway announced that it would increase its stake in each of the five trading houses to around 6%.

April 2023:

  • Buffett visited Japan for the first time in 12 years.
  • Berkshire Hathaway has escalated its stake in Japan's five major trading houses to 7.4%, marking it as the company's most substantial investment outside the United States. The firm plans to maintain its collaboration with these companies in the future.
  • Buffett expresses intention to increase holdings of Japanese stocks.

November 2023:

  • Berkshire Hathaway raised funds equivalent to $827 million USD by issuing Yen-denominated bonds, sparking expectations that he might invest more in Japan.



Source: Compiled from media reports such as Nikkei Asia.



Second Arrow: Breaking the Decades-Long Deflation Curse

The virtuous cycle of wages and inflation is expected to pull Japan out of years of deflation, achieving mild and sustainable growth in inflation and the economy. In August 2023, the Japanese government expressed that the 25-year-long battle against deflation may have reached a significant turning point.






Source: Bloomberg.
The core CPI is the Consumer Price Index excluding fresh food.



Third Arrow: “Price-to-Book Ratio Reform” Boosts Corporate Valuations

The valuation of the Japanese stock market has been low for a long time. In March 2023, the Tokyo Stock Exchange introduced a new regulation to address the situation where the Price-to-Book Ratio (PBR), which can undermine shareholder value, falls below 1. The new rule mandates that, "For listed companies with a Price-to-Book Ratio consistently below 1, it is required to disclose their policies and specific initiatives for improvement". The specific initiatives include:



Share buybacks

Short-term -
Increase Dividend

Long-term -
Improve profitability



Record Highs in Japanese Dividends and Stock Buybacks 5






5 Source: Nikkei Analysis. The stock buyback for the 2023 fiscal year is estimated data.
For illustration purpose only. Not to be constituted as a recommendation to buy/sell securities in the above-mentioned sectors or investment types.



3. Foreign Funds Flood In: A Decade-High Inflow into Japan

In 2023, overseas investors made a net purchase of Japanese stocks and futures amounting to 6.3 trillion Yen (approximately 43.39 billion USD). The net inflow of stock alone reached a scale of 3.12 trillion Yen, breaking a three-year record of net selling and setting a new high since the implementation of Abenomics in 2013.



Historic Net Purchases of Japanese Stocks and Futures by Overseas Investors (Billion Yen)





Source: Japan Exchange Group, Reuters.
For illustration purpose only. Not to be constituted as a recommendation to buy/sell securities in the above-mentioned sectors or investment types.

4. Flagship of Japanese Stocks: Nikkei 225 Index

The Nikkei Stock Average Index, also known as the Nikkei 225 Index, stands as the premier representative index for Japanese stocks on a global scale.




The Nikkei Stock Average Index (also known as the Nikkei 225 Index) 6



Selection of Constituents:
Universe: Companies listed on the Prime Market of the Tokyo Stock Exchange. To be listed on the Prime Market, companies need to have a market capitalisation of tradable shares of at least JPY10 billion, at least 800 shareholders, tradeable shares of at least 20,000 units, and a tradeable share ratio of at least 35%.

Liquidity: The top 450 (double the constituent count for the Underlying Index) of the most liquid stocks are ranked in descending order of liquidity

Industry Balance:Stocks are selected and categorised into six industrial sectors – Technology, Financials, Consumer Goods, Industrial Materials, Capital Goods/others and Transportation/Utilities. A rebalancing is conducted if any of the sectors are over-represented or under-represented
After adjusting for liquidity and industry balance, the total number of index constituents is set at 225
Type of Index:
An adjusted price-weighted equity index
A net total return index
Launch Date:
3 December 2012
Base Date and Value:
28 December 1979：6,569.47
Currency :
Japanese Yen (JPY)
Index Provider:
Nikkei Inc.
Market Cap:
29 December 2023：JPY 604.28 trillion
Number of Constituents:
225
Rebalancing Frequency:
Reviewed and rebalanced twice a year with a base date at the end of January and July, and the rebalancing results become effective on the first trading day of April and October.
Bloomberg Code:
NKYNTR


Sector Breakdown 7







The top 20 constituent stocks of the index 8



# Code Name Sector Weighting (%)
1 9983 FAST RETAILING CO., LTD. Consumer Goods 10.44%
2 8035 TOKYO ELECTRON LTD. Technology 7.43%
3 6857 ADVANTEST CORP. Technology 3.84%
4 9984 SOFTBANK GROUP CORP. Technology 3.67%
5 9433 KDDI CORP. Technology 2.77%
6 4063 SHIN-ETSU CHEMICAL CO., LTD. Materials 2.66%
7 6367 DAIKIN INDUSTRIES, LTD. Capital Goods/Others 2.30%
8 6954 FANUC CORP. Technology 2.05%
9 6762 TDK CORP. Technology 1.95%
10 4543 TERUMO CORP. Technology 1.89%
11 6098 RECRUIT HOLDINGS CO., LTD. Consumer Goods 1.69%
12 4519 CHUGAI PHARMACEUTICAL CO., LTD. Technology 1.66%
13 6971 KYOCERA CORP. Technology 1.64%
14 6758 SONY GROUP CORP. Technology 1.36%
15 7203 TOYOTA MOTOR CORP. Technology 1.35%
16 6920 LASERTEC CORP. Technology 1.32%
17 4568 DAIICHI SANKYO CO., LTD. Technology 1.28%
18 6988 NITTO DENKO CORP. Materials 1.05%
19 9735 SECOM CO., LTD. Consumer Goods 1.03%
20 9613 NTT DATA GROUP CORP. Technology 0.99%



6 Source: Nikkei.
7 Source: Nikkei, as of 1/11/2024.
8 Source: Nikkei, as of 1/11/2024.





What’s Next after Record High?



Nikkei 225 index exceeded the bubble-era high seen in December 1989 in March 2024 9, and market participants are holding mixed views for the outlook of Japanese equities.

Amid the uncertainties, Nikkei 225 leveraged and inverse products (L&Is) have been the good trading tools to capture up and down of Nikkei 225 index.




  • Increases in corporate targets for ROE, shareholder returns
  • Monetary policy remains accommodative
  • Both sales and profits were seen expansion
  • Future earnings guidance calls for profit decline
  • Japan lost crown as world’s third-largest economy and economic figures disappointed.
  • Weak Yen deters foreigners from Japanese stocks



Source: Sell-side reports, as of 2024/5/22, compiled by CSOP.
9 Bloomberg, as of 2024/5/22







CONTACT US

Phone: +852 3406 5688
Email: investorservice@csopasset.com
Address: 2801-2803, Two Exchange Square, 8 Connaught place, Central, Hong Kong
Website: www.csopasset.com



Disclaimer

This website is owned and managed by CSOP Asset Management Limited (“CSOP”). CSOP reserves the right to change, modify, add or delete, any content and the terms & conditions of use of this website without notice. Users are advised to periodically review the contents of this website to be familiar with any modifications. The performance figures contained on this website are for informational purposes only. Past performance is not indicative of future performance. Investment involves risks and the ETF's NAV per unit may rise as well as fall. Persons interested in investing in the ETF should read the relevant fund offering documents (including the full text of the risk factors stated therein) in detail before making any investment decision.

This website has been prepared by CSOP and has not been reviewed by the Securities and Futures Commission.



INVESTMENT MADE EASY
Privacy Statement Disclaimer © Copyright CSOP Asset Management Limited. All rights reserved

Privacy Statement

This is the website of CSOP Asset Management Limited. ("CSOP"). We understand that our customers and website visitors are concerned about the privacy of information. We have established policies and procedures concerning the collection, use and security of your information that will help protect your privacy. This policy statement provides information on the obligations and policies of CSOP under the Personal Data Protection Act (the "Act").

Our Corporate Policy

CSOP recognize the importance of personal data to our business and the importance of respecting the privacy rights of our clients. Therefore, we are committed to ensuring compliance with the requirements of the Act. Each employee of CSOP must abide by our commitment to privacy in the handling of personal information. To further enhance confidentiality and security of all personal data, only authorized staff will be allowed to have access to the personal information collected. It is restricted to those persons who have a business need to access personal information in order to perform their job duties.

The purpose of this Statement is to establish the policies and practices of CSOP's commitment to protect the privacy of personal data and to inform you about our responsibilities and your rights under the Act.

Types of Personal Data Held

There are two broad categories of personal data held by us. They are personal data relating to clients and employees of CSOP.

Personal data held by us regarding clients may include the following:
Personal data relating to employment held by us may include the following:

Main Purposes of keeping Personal Data

The purposes for which personal data relating to clients may be used are as follows:
The purposes for which personal data relating to employees may be used are as follows:
Transfer of Personal Data

Personal data held by CSOP relating to clients will be kept confidential but may be transferred to the following parties (whether within or outside Singapore) for any of the purposes stated above:

Accuracy of Personal Data

CSOP strive at all times to ensure accuracy of all personal data collected and processed by us. In order to assist us to deliver on this pledge, please inform us immediately in the event that your personal information has been changed or you discovered that your personal information held by us is incorrect.

Your Rights

It is not a statutory requirement for you to provide personal data to us. However, we will not be able to provide you with the services and products you may require unless you provide us with the necessary personal data or information.

You have a right (i) to be informed whether we hold any of your personal data; (ii) to be supplied with a copy of your personal data we hold; (iii) to request correction of your personal data we hold; and (iv) to object to the use of your personal data for marketing purposes.

If you wish to access to and/or to correct any of your personal data held by us, please send your written request to the address set out below. We may, subject to the Act, impose a reasonable fee for complying with a data access request.

If you do not wish your personal data to be used for direct marketing purposes, you may notify us in writing to the following address.

If you have any questions or would like further information on our privacy and information handling practices or would like to exercise any of these rights, please address them to:



Data Protection Officer
CSOP Asset Management Limited.,
#18-03 Millenia Tower,
One Temasek Avenue,
Singapore 039192

Upon receipt of such notice, we shall, without charge to you, cease using your personal data for direct marketing purposes.

Disclaimer

CSOP Asset Management Limited. ("CSOP") is a regulated financial institution in Singapore by the Monetary Authority of Singapore (“MAS”). This website contains information about CSOP and the services and products offered by CSOP. The information provided on the CSOP website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country that would subject CSOP or its affiliates to any registration requirement within such jurisdiction or country. Non-Singapore investors are responsible for observing all applicable laws and regulations of their relevant jurisdictions before proceeding to access the information contained herein. By proceeding, you are representing that you have understood and accepted the restrictions set out in this section.

The website is prepared by CSOP and has not been reviewed by the MAS. You are advised to exercise caution and if you are in any doubt about any of the contents of the website, you should obtain independent financial and professional advice. Private Investors are advised to consult with their financial advisors, banks, or other professional advisors. Nothing herein should be construed as investment advice nor as comment on the suitability of any investment or investment service. Prospective investors should take advice from their own professional advisors before making any investment decision.

The information contained in this website is provided for reference only and does not constitute any investment advice, offer or solicitation to deal in any investments mentioned herein. The information on the website is being provided strictly for informational purposes only and does not constitute an advertisement and/or investment advice. The information and/or data herein has been obtained from sources that CSOP believes to be reliable and accurate at the time of issue but no representation or warranty, expressed or implied, is made as to the fairness, accuracy, completeness or correctness of the information. Neither CSOP, nor any of its associates, nor any director, officer or employee accepts any liability whatsoever for any loss arising directly or indirectly from any use of this document.

Past performance is not an indicative of future performance. Investment involves risk and investors may not get back the amount originally invested. Please note that the value of investments and the income from them may go down as well as up and that you may not get back your original investment. Please read the relevant offering document including the risk factors carefully, in particular fund features and the risks involved in investing in the fund. You should ensure you fully understand the risks associated with the investment and should also consider your own investment objective and risk tolerance level. If in doubt, please seek independent financial professional advice.

Nothing on this website constitutes a solicitation, invitation, recommendation or offer to purchase a product offered by CSOP or any CSOP funds or as the basis for any investment decision.

This site may include forward-looking statements which are based on CSOP's current opinions, expectations and projections. CSOP undertake no obligation to update or revise any forward-looking statements. Actual results could differ materially from those anticipated in the forward-looking statements.

If you have accessed this site using a link from another site, CSOP do not accept any liability or responsibility for the accuracy of information contained within the sites of other providers who have links to any pages of this site.

Cookies

CSOP do not accept responsibility for any interference or damage to your own computer system, the records stored therein or those of any other person, which arises in connection with your use of this website or any linked website. A Cookies is utilized on this website. It allows your browser to check whether you have read and agreed to these terms. The Cookies does not contain any personally identifiable information. Unfortunately, if your browser is set up to reject Cookies you will not be able to see the content of this website. All copyrights reserved and its contents including all information, graphics, code, text and design in this website are owned by CSOP and should not be reproduced or distributed without its permission. These terms are governed exclusively by the laws of the Republic of Singapore and constitute the entire agreement between you and CSOP in relation to the use of this website.

Links to other web sites

Our web site may contain links to non-CSOP websites, including websites of its related corporation and/or associates, that are independent from our website. While such links are provided for your convenience, you should be aware that the information handling practices of the linked websites might not be the same as ours and that CSOP has no control over the content or availability of that website. You should review any privacy policies on those linked websites. The use of such links is entirely at your own risk and CSOP accepts no responsibility for the content, or the use of, such a site and shall not be liable for any loss or damage caused or alleged to be caused by or in connection with use of or reliance on any such content, goods or services available on or through any such site or resource.

The information is current as at the date of publication but is subject to change without prior notice. This website is issued by CSOP Asset Management Limited. whose company registration number is 201814646Z and has not been reviewed by the Monetary Authority of Singapore.